Technique rapidly measures cells’ density, reflecting health and developmental state
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
Ultraviolet light “fingerprints” on cell cultures and machine learning can provide a definitive yes/no contamination assessment within 30 minutes.
The technology, which achieves single-cell resolution, could help in continuous, noninvasive patient assessment to guide medical treatments.
Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.
CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.
The research may enable the design of synthetic, light-activated cells for wound healing or drug delivery.
MIT engineers developed a way to grow artificial tissues that look and act like their natural counterparts.
A new, highly efficient process for performing this conversion could make it easier to develop therapies for spinal cord injuries or diseases like ALS.
New methods light up lipid membranes and let researchers see sets of proteins inside cells with high resolution.
FragFold, developed by MIT Biology researchers, is a computational method with potential for impact on biological research and therapeutic applications.
Whitehead Institute and CSAIL researchers created a machine-learning model to predict and generate protein localization, with implications for understanding and remedying disease.
Studying the pathogen R. parkeri, researchers discovered the first evidence of extensive and stable interkingdom contacts between a pathogen and a eukaryotic organelle.
New findings illuminate how Prochlorococcus’ nightly “cross-feeding” plays a role in regulating the ocean’s capacity to cycle and store carbon.